Stifel Financial’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.21M | Sell |
68,666
-12,646
| -16% | -$1.16M | 0.01% | 1225 |
|
|
2025
Q4 | $7.31M | Sell |
81,312
-8,342
| -9% | -$791K | 0.01% | 1125 |
|
|
2025
Q3 | $8.83M | Sell |
89,654
-6,589
| -7% | -$653K | 0.01% | 1003 |
|
|
2025
Q2 | $8.78M | Buy |
96,243
+4,217
| +5% | +$408K | 0.01% | 953 |
|
|
2025
Q1 | $10.4M | Sell |
92,026
-4,006
| -4% | -$429K | 0.01% | 822 |
|
|
2024
Q4 | $10.1M | Buy |
96,032
+9,341
| +11% | +$1M | 0.01% | 843 |
|
|
2024
Q3 | $9.36M | Sell |
86,691
-13,872
| -14% | -$1.51M | 0.01% | 870 |
|
|
2024
Q2 | $10.9M | Sell |
100,563
-36,086
| -26% | -$4.25M | 0.01% | 784 |
|
|
2024
Q1 | $18M | Sell |
136,649
-13,039
| -9% | -$1.63M | 0.02% | 591 |
|
|
2023
Q4 | $18.2M | Sell |
149,688
-63,608
| -30% | -$7.1M | 0.02% | 546 |
|
|
2023
Q3 | $23.9M | Sell |
213,296
-41,067
| -16% | -$5.22M | 0.03% | 421 |
|
|
2023
Q2 | $37M | Buy |
254,363
+15,831
| +7% | +$2.15M | 0.05% | 315 |
|
|
2023
Q1 | $30.8M | Sell |
238,532
-1,823
| -0.8% | -$229K | 0.04% | 353 |
|
|
2022
Q4 | $30.6M | Sell |
240,355
-10,361
| -4% | -$1.2M | 0.05% | 341 |
|
|
2022
Q3 | $26.2M | Buy |
250,716
+6,847
| +3% | +$751K | 0.04% | 353 |
|
|
2022
Q2 | $25.6M | Buy |
243,869
+17,145
| +8% | +$2.03M | 0.04% | 373 |
|
|
2022
Q1 | $29M | Buy |
226,724
+11,985
| +6% | +$1.44M | 0.04% | 383 |
|
|
2021
Q4 | $26.5M | Sell |
214,739
-87,507
| -29% | -$11.5M | 0.04% | 414 |
|
|
2021
Q3 | $42.9M | Sell |
302,246
-31,029
| -9% | -$4.56M | 0.06% | 271 |
|
|
2021
Q2 | $52M | Buy |
333,275
+45,077
| +16% | +$7.3M | 0.08% | 241 |
|
|
2021
Q1 | $44.8M | Buy |
288,198
+226,101
| +364% | +$35M | 0.07% | 250 |
|
|
2020
Q4 | $9.29M | Buy |
62,097
+6,671
| +12% | +$942K | 0.02% | 623 |
|
|
2020
Q3 | $7.33M | Sell |
55,426
-8,055
| -13% | -$1.05M | 0.02% | 629 |
|
|
2020
Q2 | $7.36M | Buy |
63,481
+3,407
| +6% | +$393K | 0.02% | 598 |
|
|
2020
Q1 | $5.9M | Sell |
60,074
-24,727
| -29% | -$3.24M | 0.02% | 612 |
|
|
2019
Q4 | $12.3M | Buy |
84,801
+11,664
| +16% | +$1.61M | 0.03% | 527 |
|
|
2019
Q3 | $9.76M | Sell |
73,137
-18,388
| -20% | -$2.38M | 0.02% | 560 |
|
|
2019
Q2 | $10.5M | Buy |
91,525
+28,663
| +46% | +$3.36M | 0.03% | 557 |
|
|
2019
Q1 | $7.8M | Buy |
62,862
+4,216
| +7% | +$479K | 0.02% | 628 |
|
|
2018
Q4 | $5.9M | Buy |
58,646
+13,642
| +30% | +$1.53M | 0.02% | 694 |
|
|
2018
Q3 | $5.75M | Buy |
45,004
+1,003
| +2% | +$119K | 0.02% | 780 |
|
|
2018
Q2 | $4.75M | Buy |
44,001
+7,955
| +22% | +$866K | 0.01% | 842 |
|
|
2018
Q1 | $3.8M | Sell |
36,046
-70,046
| -66% | -$8.13M | 0.01% | 900 |
|
|
2017
Q4 | $12.4M | Buy |
106,092
+33,486
| +46% | +$3.79M | 0.04% | 440 |
|
|
2017
Q3 | $8.27M | Sell |
72,606
-12,968
| -15% | -$1.5M | 0.03% | 572 |
|
|
2017
Q2 | $10.7M | Sell |
85,574
-17,169
| -17% | -$2.04M | 0.04% | 446 |
|
|
2017
Q1 | $12.2M | Sell |
102,743
-26,810
| -21% | -$3.04M | 0.05% | 388 |
|
|
2016
Q4 | $13M | Buy |
129,553
+30,866
| +31% | +$3.31M | 0.06% | 341 |
|
|
2016
Q3 | $12.5M | Sell |
98,687
-15,435
| -14% | -$1.91M | 0.06% | 324 |
|
|
2016
Q2 | $13.3M | Buy |
114,122
+7,505
| +7% | +$849K | 0.06% | 309 |
|
|
2016
Q1 | $11M | Sell |
106,617
-5,877
| -5% | -$569K | 0.06% | 306 |
|
|
2015
Q4 | $11.2M | Buy |
112,494
+21,076
| +23% | +$2.06M | 0.06% | 327 |
|
|
2015
Q3 | $8.34M | Buy |
91,418
+7,107
| +8% | +$712K | 0.05% | 376 |
|
|
2015
Q2 | $8.94M | Sell |
84,311
-9,632
| -10% | -$1.07M | 0.05% | 399 |
|
|
2015
Q1 | $10.7M | Sell |
93,943
-9,434
| -9% | -$1.08M | 0.06% | 380 |
|
|
2014
Q4 | $11.4M | Buy |
103,377
+4,844
| +5% | +$511K | 0.06% | 365 |
|
|
2014
Q3 | $9.62M | Buy |
98,533
+3,302
| +3% | +$325K | 0.08% | 288 |
|
|
2014
Q2 | $9.6M | Sell |
95,231
-4,084
| -4% | -$398K | 0.09% | 288 |
|
|
2014
Q1 | $9.12M | Buy |
+99,315
| New | +$9.15M | 0.09% | 295 |
|
Other funds holding ZBH
VCM
VPM
Stifel Financial's ZBH Position: Q1 2026 in Review
Stifel Financial reduced its Zimmer Biomet (ZBH) stake by 16% in Q1 2026, selling an estimated $1.16M and leaving 68,666 shares worth $6.21M. The position accounts for 0.01% of the portfolio, ranked #1225.
Stifel Financial first reported a position in ZBH in Q1 2014 and has held it in 49 quarters since. The position peaked at $52M in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Stifel Financial held 68,666 shares of Zimmer Biomet worth $6.21M as of Q1 2026.
- Stifel Financial sold 12,646 Zimmer Biomet shares in Q1 2026, an estimated $1.16M.
- Zimmer Biomet made up 0.01% of Stifel Financial's portfolio in Q1 2026, its #1225 holding.
- Stifel Financial first reported a position in Zimmer Biomet in Q1 2014 and has held it in 49 quarters since.
- Stifel Financial's Zimmer Biomet position peaked at $52M in Q2 2021.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.